Stockholders' Equity |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Stockholders' Equity Note [Abstract] | |
| Stockholders' Equity [Text Block] |
7. Stockholders' Equity The Company's common stock has a par value of $0.001 with 200,000,000 shares authorized. The Company also has 5,000,000 authorized shares of preferred stock with a par value of $0.0001. The Company also has 26,539,313 warrants outstanding as of September 30, 2026, with a weighted average exercise price of $0.31 and a weighted average life of 1.12 years. During the nine months ended September 30, 2026, the Company issued 4,139,313 warrants in connection with its August 2026 private placement, including 94,089 finder warrants, each exercisable at $1.00 per share for a period of 24 months from the date of issuance. No warrants were exercised or expired during the nine months ended September 30, 2026. During the nine months ended September 30, 2026, the Company issued 250,000 shares of common stock upon the exercise of stock options for cash proceeds of $40,000. In August 2026, the Company completed a private placement of 8,090,451 units at $0.70 per unit for gross proceeds of $5,663,316. Each unit consists of one share of common stock and one-half of one common stock purchase warrant. Each whole warrant entitles the holder to purchase one additional share of common stock at an exercise price of $1.00 for a period of 24 months from the date of issuance. The Company incurred issuance costs of $162,012, of which $104,012 was paid during the period and $58,000 was included in accounts payable and other accrued liabilities at September 30, 2026. In addition, the 94,089 finder warrants issued to brokers had a fair value of $62,170. Total issuance costs of $224,182 were recorded as a reduction of additional paid-in capital. |